SREBP-‐1c, ChREBPy LXR…
45
135.
Cha, J.Y., Repa, J.J., 2007. The liver X receptor (LXR) and hepatic lipogenesis. The
carbohydrate-‐response element-‐binding protein is a target gene of LXR. J Biol Chem282,
743-‐751.
136.
Gauthier, K., Billon, C., Bissler, M. y col. 2010. Thyroid hormone receptor beta
(TRbeta) and liver X receptor (LXR) regulate carbohydrate-‐response element-‐binding
protein(ChREBP) expression ina tissue-‐selectivemanner. JBiol Chem285, 28156-‐28163.
137.
Iizuka, K., Bruick, R.K., Liang, G. y col. 2004. Deficiency of carbohydrate response
element-‐binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl
AcadSciUSA101, 7281-‐7286.
138.
Repa, J.J., Liang, G., Ou, J. y col. 2000. Regulation of mouse sterol regulatory
element-‐binding protein-‐1c gene (SREBP-‐1c) by oxysterol receptors, LXRalpha and
LXRbeta. GenesDev14, 2819-‐2830.
139.
Sirek, A.S., Liu, L., Naples, M. y col. 2009. Insulin stimulates the expression of
carbohydrate response element binding protein (ChREBP) by attenuating the repressive
effect of Pit-‐1, Oct-‐1/Oct-‐2, and Unc-‐86 homeodomain protein octamer transcription
factor-‐1. Endocrinology150, 3483-‐3492.
140.
Havula, E., Hietakangas, V., 2012. Glucose sensing by ChREBP/MondoA-‐Mlx
transcription factors. SeminCellDevBiol 23, 640-‐647.
141.
Hurtado del Pozo, C., Vesperinas-‐García, G., Rubio, M. y col. 2011. ChREBP
expression in the liver, adipose tissue and differentiated preadipocytes in human obesity.
BiochimBiophysActa1811, 1194-‐1200.
142.
Benhamed, F., Denechaud, P.D., Lemoine, M. y col. 2012. The lipogenic
transcription factor ChREBP dissociates hepatic steatosis from insulin resistance inmice
andhumans. J Clin Invest 122, 2176-‐2194.
143.
Dentin, R., Benhamed, F., Hainault, I. y col.2006. Liver-‐specific inhibition of
ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55,
2159-‐2170.
144.
Iizuka, K., Takeda, J., Horikawa, Y., 2009. Hepatic overexpression of dominant
negative Mlx improves metabolic profile in diabetes-‐prone C57BL/6J mice. Biochem
BiophysResCommun379, 499-‐504.
145.
Robichon, C., Girard, J., Postic, C., 2008. [Can thehyperactivityof lipogenesis cause
hepatic steatosis?Arole forChREBP].MedSci (Paris)24, 841-‐846.
146.
Lodhi, I.J., Wei, X., Semenkovich, C.F., 2011. Lipoexpediency: de novo lipogenesis
as ametabolic signal transmitter. TrendsEndocrinolMetab22, 1-‐8.
147.
Charlton, M.R., 2013. ChREBP inNASH -‐ a liver transcription factor comes in from
thecold. JHepatol 59, 178-‐179.
148.
Färnegårdh, M., Bonn, T., Sun, S. y col. 2003. The three-‐dimensional structure of
the liver X receptor beta reveals a flexible ligand-‐binding pocket that can accommodate
fundamentallydifferent ligands. JBiol Chem278, 38821-‐38828.
149.
Peet, D.J., Turley, S.D.,Ma,W. y col. 1998. Cholesterol andbile acidmetabolismare
impaired inmice lacking thenuclearoxysterol receptorLXRalpha. Cell 93, 693-‐704.
150.
Blaschke, F., Takata, Y., Caglayan, E. y col. 2006. A nuclear receptor corepressor-‐
dependent pathway mediates suppression of cytokine-‐induced C-‐reactive protein gene
expressionby liverXreceptor. CircRes99, e88-‐99.
151.
Willy, P.J., Umesono, K., Ong, E.S. y col. 1995. LXR, anuclear receptor that defines a
distinct retinoidresponsepathway. GenesDev9, 1033-‐1045
152.
Zhang, Y., Repa, J.J., Gauthier, K., Mangelsdorf, D.J., 2001. Regulation of lipoprotein
lipaseby theoxysterol receptors, LXRalphaandLXRbeta. JBiol Chem276, 43018-‐43024.
153.
Korach-‐André, M., Parini, P., Larsson, L. y col. 2010. Separate and overlapping
metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice. Am J Physiol
EndocrinolMetab298, E167-‐178.
154.
Korach-‐André, M., Archer, A., Barros, R.P. y col. 2011. Both liver-‐X receptor (LXR)
isoforms control energyexpenditureby regulatingbrownadipose tissueactivity. ProcNatl
AcadSciUSA108, 403-‐408.
155.
Viennois, E., Pommier, A.J., Mouzat, K. y col. 2011. Targeting liver X receptors in
humanhealth: deadlockorpromising trail?ExpertOpinTherTargets15, 219-‐232.
156.
Chen, J.D., Evans, R.M., 1995. A transcriptional co-‐repressor that interacts with
nuclearhormone receptors. Nature377, 454-‐457.
